Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20459955 | 0.82 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20459995 | 0.81 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20460012 | 0.80 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20460051 | 0.79 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL21373703 | 0.79 | CYP11B2 (0.67) | CYP11B2CYP11B1 | |
| SCHEMBL20460032 | 0.79 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20460009 | 0.78 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL16797374 | 0.77 | CYP11B2 (0.63) | CYP11B2CYP11B1 | |
| SCHEMBL20460011 | 0.77 | CYP11B2 (1.00) | CYP11B2CYP11B1 | |
| SCHEMBL20460019 | 0.77 | CYP11B2 (0.64) | CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018141541-A1 | COMPOUND FOR IN VIVO DIAGNOSIS OF A DYSFUNCTION OF ADRENAL GLANDS | JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) | 2018-08-09 | — | — | WO | disclosed |
| EP-3357910-A1 | COMPOUND FOR IN VIVO DIAGNOSIS OF A DYSFUNCTION OF ADRENAL GLANDS | Julius-Maximilians-Universität Würzburg (DE) | 2018-08-08 | — | — | EP | disclosed |
| US-20160067353-A1 | PROTEIN-POLYMER-DRUG CONJUGATES | MERSANA THERAPEUTICS, INC. | 2016-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160067353-A1 | PROTEIN-POLYMER-DRUG CONJUGATES | PBRM1, CLTB, BRAP | CYP11B2 4511/4885CYP11B1 4368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.